← Leaderboards
Donna Kritz-Silverste
University Of California San Diego
$0
Attributed
$0
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 1
By mechanism
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Barbara L Parry$15,581,120
- Michael R Irwin$42,103,262
- John C Gillin$665,812
- Elizabeth L Barrett-Connor$23,063,939
- Dilip V Jeste$42,629,237
Others in their field
Top investigators on “Blood Pressure”
- David R. Weir · University Of Michigan At Ann Arbor$96,362,652
- Michael A Province · Washington University$60,417,406
- Leonardo Trasande · New York University School Of Medicine$55,277,738
- Rohit Varma · University Of Southern California$55,238,158
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$54,376,013
- Jiang He · Tulane University Of Louisiana$45,164,948
Research focus
Blood PressureBone DensityCardiovascular DisorderCholesterolClinical ResearchDepressionDisease /Disorder Proneness /RiskFemaleGlucoseHigh Density LipoproteinsHuman SubjectHuman Therapy EvaluationInsulinOutcomes ResearchPhytoestrogensPostmenopauseQuality Of LifeSatisfactionSocial PsychologyWomen'S Health
Grant awards (9)
CVD RISK IN HEALTHY AND IN POSTMENOPAUSE PHYTOESTROGEN USERS$0
M01 · FY2002 · RR
CVD RISK IN HEALTHY AND IN POSTMENOPAUSE PHYTOESTROGEN USERS$0
M01 · FY2002 · RR
CVD RISK IN HEALTHY AND IN POSTMENOPAUSE PHYTOESTROGEN USERS$0
M01 · FY2002 · RR
CVD RISK IN HEALTHY AND IN POSTMENOPAUSE PHYTOESTROGEN USERS$0
M01 · FY2002 · RR
CVD RISK IN HEALTHY AND IN POSTMENOPAUSE PHYTOESTROGEN USERS$0
M01 · FY2001 · RR
CVD RISK IN HEALTHY AND IN POSTMENOPAUSE PHYTOESTROGEN USERS$0
M01 · FY2001 · RR
CVD RISK IN HEALTHY AND IN POSTMENOPAUSE PHYTOESTROGEN USERS$0
M01 · FY2000 · RR
CVD RISK IN HEALTHY AND IN POSTMENOPAUSE PHYTOESTROGEN USERS$0
M01 · FY2000 · RR
CVD RISK IN HEALTHY AND IN POSTMENOPAUSE PHYTOESTROGEN USERS$0
M01 · FY2000 · RR